PCDHA10, or Protocadherin Alpha 10, is a member of the protocadherin family, a group of molecules that play crucial roles in the nervous system, particularly in neural development and function. This gene is part of the protocadherin alpha gene cluster, one of three related clusters all residing within the human chromosome 5. These clusters are notable for their involvement in the formation of neural circuits and for their unique expression patterns in the nervous system.PCDHA10, like other protocadherins, is characterized by its cadherin domains, which are key for cell-cell adhesion. This adhesion is essential for the proper formation and maintenance of synapses in the brain. The protein encoded by this gene is a single-pass type I membrane protein, meaning it crosses the cell membrane once and has most of its structure outside the cell. This positioning allows it to interact with other cells and proteins in the extracellular environment.
The expression of PCDHA10 is highly specific to the brain and has been implicated in various neural processes, including synaptic plasticity, which is the ability of synapses to strengthen or weaken over time. This plasticity is fundamental to learning and memory.Additionally, PCDHA10 and other protocadherins are involved in the establishment of specific neural connections during brain development. Abnormalities in these proteins can lead to various neurological disorders, highlighting their importance in brain health and function.Overall, PCDHA10 is a crucial component in the complex network of molecular interactions that underpin the development, function, and plasticity of the nervous system.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $65.00 $319.00 $575.00 $998.00 | 28 | |
Retinoic Acid is involved in neural differentiation, potentially influencing PCDHA10 in neurodevelopmental processes. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Forskolin activates adenylate cyclase, potentially influencing signaling pathways relevant to PCDHA10's function. | ||||||
Taurine | 107-35-7 | sc-202354 sc-202354A | 25 g 500 g | $47.00 $100.00 | 1 | |
Taurine is involved in neuronal development and might influence pathways where PCDHA10 is active. | ||||||
Adenosine 3′,5′-cyclic monophosphate | 60-92-4 | sc-217584 sc-217584A sc-217584B sc-217584C sc-217584D sc-217584E | 100 mg 250 mg 5 g 10 g 25 g 50 g | $114.00 $175.00 $260.00 $362.00 $617.00 $1127.00 | ||
cAMP is a key second messenger in neurons, potentially affecting PCDHA10's role in neural signaling and plasticity. | ||||||
Fluoxetine | 54910-89-3 | sc-279166 | 500 mg | $312.00 | 9 | |
Fluoxetine, an SSRI, can affect neurogenesis and synaptic plasticity, potentially impacting PCDHA10 function. | ||||||
D-Serine | 312-84-5 | sc-391671 sc-391671A sc-391671B | 5 g 25 g 100 g | $42.00 $125.00 $200.00 | ||
D-serine acts as a co-agonist at NMDA receptors, potentially modulating synaptic function related to PCDHA10. | ||||||
Vinpocetine | 42971-09-5 | sc-201204 sc-201204A sc-201204B | 20 mg 100 mg 15 g | $55.00 $214.00 $2400.00 | 4 | |
Vinpocetine, a phosphodiesterase inhibitor, might affect neuronal signaling pathways involving PCDHA10. | ||||||
D,L-Sulforaphane | 4478-93-7 | sc-207495A sc-207495B sc-207495C sc-207495 sc-207495E sc-207495D | 5 mg 10 mg 25 mg 1 g 10 g 250 mg | $150.00 $286.00 $479.00 $1299.00 $8299.00 $915.00 | 22 | |
Sulforaphane, found in cruciferous vegetables, has been shown to influence neurodevelopmental processes. | ||||||
Acetyl-L-carnitine chloride | 5080-50-2 | sc-210747 | 1 g | $52.00 | ||
Acetyl-L-carnitine has neuroprotective and neurotrophic properties, potentially impacting PCDHA10 activity. | ||||||